staphylococcus aureus -...

1

Curso práctico para mejorar el uso de los antimicrobianos en los principales síndromes de las infecciones graves

TEMA 13. BACTERIEMIA POR STAPHYLOCOCCUS AUREUS

TEMA 13. Bacteriemia por Staphylococcus aureus

José Mª Reguera y L. Eduardo López Cortés Bibliografía recomendada: - Daniel R. Kaul, Scott A. Flanders, James M. Beck, et al. BRIEF REPORT: Incidence, Etiology,

Risk Factors, and Outcome of Hospital-acquired Fever. A Systematic, Evidence-based Review. J Gen Intern Med. 2006; 21: 1184–1187.

- Arbo MJ, Fine MJ, Kapoor WN, et al. Fever of nosocomial origin: etiology, risk factors, and

outcomes. Am J Med. 1993; 95(5): 505-1. - Patel RA, Gallagher RA. Drug fever. Pharmacotherapy 2010; 30(1): 57-69. - José Miguel Cisneros, Javier Cobo, Miquel Pujol, Jesús Rodríguez-Baño y Miguel Salavert.

Guía para el diagnóstico y tratamiento del paciente con bacteriemia. Guías de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Enferm Infecc Microbiol Clin 2007; 25(2): 111-30.

- José Manuel Lomas Cabezas, Rafael Luque Márquez. Documento de Consenso sobre

Infecciones relacionadas con catéteres vasculares (SAEI). Grupo para el Estudio de las Infecciones Cardiovasculares de la SAEI. Avances en Enfermedades Infecciosas. Vol 12. supl 1. 2011.

- Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign guidelines committee including the pediatric subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2013; 41(2): 580-637.

- Derek C. Angus and Tom van der Poll. Severe Sepsis and Septic Shock. N Engl J Med 2013; 369: 840-51.

- Mervyn Singer, Clifford S. Deutschman, Christopher Warren Seymour, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8): 801-810.

- Carlos Pigrau. Infecciones del tracto urinario nosocomiales. Enferm Infecc Microbiol Clin.

2013; 31(9): 614–624.

- Thomas M. Hooton, Suzanne F. Bradley, Diana D. Cardenas, et al. Diagnosis, Prevention, and Treatment of Catheter- Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010; 50: 625–663.

2



- Miquel Pujol y Enric Limón. Epidemiología general de las infecciones nosocomiales.

Sistemas y programas de vigilancia. Enferm Infecc Microbiol Clin.2013; 31(2): 108–113.

- Anand Kumar, Paul Ellis, Yaseen Arabi, et al. Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock. CHEST 2009; 136: 1237–1248.

- Carmen Ferrer y Benito Almirante. Infecciones relacionadas con el uso de los catéteres vasculares. Enferm Infecc Microbiol Clin. 2014; 32(2): 115–124.

- Francesc Gudiol, José María Aguado, Benito Almirante, et al.Diagnosis and treatment of

bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enferm Infecc Microbiol Clin. 2015; 33(9): 625.e1–625.e23.

- Jesús Rodríguez-Baño, José Miguel Cisneros, Nazaret Cobos-Trigueros, et al. Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology. Enferm Infecc Microbiol Clin. 2015; 33(5): 337.e1–337.e21.

- José Mensa, Alex Soriano, Pedro Llinares, et al. Guía de tratamiento antimicrobiano de la infección por Staphylococcus aureus. Rev Esp Quimioter 2013; 26 (Suppl. 1): 1-84.

- Kevin W. McConeghy, Susan C. Bleasdale, and Keith A. Rodvold. The Empirical Combination of Vancomycin and a β-Lactam for Staphylococcal Bacteremia. Clin Infect Dis. 2013; 57(12): 1760–1765.

- Joan Barenfanger, Donald R. Graham, Lavanya Kolluri, et al. Decreased Mortality Associated With Prompt Gram Staining of Blood Cultures. Am J Clin Pathol. 2008; 130: 870-876.

- Jesús Rodríguez-Baño, José Ramón Paño-Pardo, Luis Alvarez-Rocha, et al. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH. Enferm Infecc Microbiol Clin. 2012; 30(1): 22.e1–22.e23.

- Timothy C. Jenkins, Connie S. Price, Allison L. Sabel, et al. Impact of Routine Infectious Diseases Service Consultation on the Evaluation, Management, and Outcomes of Staphylococcus aureus Bacteremia. Clin Infect Dis. 2008; 46: 1000–8.

3



- E. Forsblom, E. Ruotsalainen, J. Ollgren, et al. Telephone Consultation Cannot Replace Bedside Infectious Disease Consultation in the Management of Staphylococcus aureus Bacteremia. Clin Infect Dis. 2013; 56(4): 527–35.

- Elena Jordana-Lluch, Elisa Martró Catala y Vicente Ausina Ruiz. La espectrometría de masas en el laboratorio de microbiología clínica. Enferm Infecc Microbiol Clin. 2012; 30(10): 635–644.

- D. M. Wolk, M. J. Struelens, P. Pancholi, et al. Rapid Detection of Staphylococcus aureus and Methicillin-Resistant S. aureus (MRSA) in Wound Specimens and Blood Cultures: Multicenter Preclinical Evaluation of the Cepheid Xpert MRSA/SA Skin and Soft Tissue and Blood Culture Assays. J. Clin. Microbiol. 2009; 47(3): 823-826.

- O. Clerc, G. Prod’hom, L. Senn, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry and PCR-based rapid diagnosis of Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2014; 20: 355–360.

- Leonard A. Mermel, Michael Allon, Emilio Bouza, et al. Clinical Practice Guidelines for the

Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 49: 1–45.

- Aguado JM, San-juan R, Lalueza A, et al. High Vancomycin MIC and Complicated Methicillin

Susceptible Staphylococcus aureus Bacteriemia. Emerg Infect Dis. 2011; 17: 1099–102.

- Castón JJ, González-Gasca F, Porras L, et al. High vancomycin minimum inhibitory concentration is associated with poor outcome in patients with methicillin-susceptible Staphylococcus aureus bacteremia regardless of treatment. Scand J Infect Dis 2014; 46: 783–6.

- Howden BP, Davies JK, Johnson PD, et al. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010; 23: 99–139.

- López-Cortés LE, Velasco C, Retamar P, del Toro MD, Gálvez-Acebal J, de Cueto M, García-

Luque I, Caballero FJ, Pascual A, Rodríguez-Baño J. Is reduced vancomicin susceptibility a factor associated a poor prognosis in MSSA bacteraemia. J Antimicrob Chemother. 2015; 70(9): 2652-60.

- Marin L Schweizer, Jon P Furuno, Anthony D Harris. Et al. Comparative effectiveness of

nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infec Dis. 2011, 11: 279-286.

4



- Shinwon Lee, Pyoeng Gyun Choe, Kyoung-Ho Song, et al. Is Cefazolin Inferior to Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia? Antimicrob agents Chemother. 2011; 55(11): 5122-5126.

- Jennifer H. Han, Kara B. Mascitti, Paul H. Edelstein et al. Effect of Reduced Vancomycin Susceptibility on Clinical and Economic Outcomes in Staphylococcus aureus Bacteremia. Antimicrob agents Chemother. 2012; 56(10): 5164-5170.

- Francesc Gudiol, José María Aguado, Benito Almirante, et al. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enferm infecc Microbiol clin. 2015; 33(9): 625 e1- 625 e23.

- Claire M Rickard, Joan Webster, Marianne C Wallis, et al. Routine versus clinically indicated

replacement of peripheral intravenous catheters: a randomised controlled equivalence trial.

- Lancet 2012; 380: 1066–74.

- Vance G. Fowler, Jr., Anita Justice, Catrin Moore, et al. Risk Factors For Hematogenous

Complications of Intravascular Catheter–Associated Staphylococcus aureus Bacteremia. Clin Infect Dis. 2005; 40: 695–703.

- Yong Pil Chong, Song Mi Moon, Kyung-Mi Bang, et al. Treatment Duration for Uncomplicated Staphylococcus aureus Bacteremia To Prevent Relapse: Analysis of a Prospective Observational Cohort Study. Antimicrob Agents and Chemother. 2013: 57(3): 1150-1156.

- Fowler VG Jr, Justice A, Moore C, et al. Risk factors for hematogenous complications of

intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40(5):695-703.

- Fowler VG Jr, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003; 163(17):2066-72.

- Fowler VG Jr, Justice A, Moore C, et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005; 40(5):695-703.

- López-Cortés LE, Del Toro MD, Gálvez-Acebal J, et al; REIPI/SAB group. Impact of an

evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013; 57(9):1225-33.

5



- Gudiol F, Aguado JM, Almirante B, et al. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enferm Infecc Microbiol Clin. 2015;33(9):625.e1-625.e23.

- Barton T, Moir S, Rehmani H, et al. Low rates of endocarditis in healthcare-associated Staphylococcus aureus bacteremia suggest that echocardiography might not always be required. Eur J Clin Microbiol Infect Dis. 2016; 35(1):49-55.

- Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA. 2014;312(13):1330-41.

- Park KH, Lee YM, Hong HL, et al. Persistent catheter-related Staphylococcus aureus

bacteremia after catheter removal and initiation of antimicrobial therapy. PLoS One. 2012;7(10):e46389.

- Jung J, Lee J, Yu SN, et al. Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2016; 60(4):2012-7.

- Keene AB. Thrombosis in central catheter-associated Staphylococcus aureus bacteremia: always scan the site? Crit Care Med. 2008; 36(2):618-9.

- Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 2013;61:2374–2382.

- Erba PA, Conti U, Lazzeri E, et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med 2012;53:1235–1243.

- Gudiol F, Aguado JM, Almirante B, et al. Diagnosis and treatment of bacteremia and

endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enferm Infecc Microbiol Clin. 2015;33(9):625.e1-625.e23.

- Palraj BR, Baddour LM, Hess EP, et al. Predicting Risk of Endocarditis Using a Clinical Tool

(PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia. Clin Infect Dis. 2015;61(1):18-28.

- Rouzet F, Chequer R, Benali K, et al. Respective performance of 18F-FDG PET and

radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med 2014;55:1980–1985.

6



- Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128.

- Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus

bacteremia: a review. JAMA. 2014;312(13):1330-41.


- Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of

infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128.

- Vogel M, Schmitz RP, Hagel S, et al. Infectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis. J Infect. 2016; 72(1):19-28.

- López-Cortés LE, Del Toro MD, Gálvez-Acebal J, et al; REIPI/SAB group. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013; 57(9):1225-33.

- Rao SN, Rhodes NJ, Lee BJ, et al. Treatment outcomes with cefazolin versus oxacillin for

deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2015; 59(9):5232-8.

- Bai AD, Showler A, Burry L, et al. Comparative effectiveness of cefazolin versus cloxacillin as

definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. J Antimicrob Chemother. 2015; 70(5):1539-46.

- Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA. 2014;312(13):1330-41.

- Fowler VG Jr, Justice A, Moore C, et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005; 40(5):695-703.

7




- Mzabi A, Kernéis S, Richaud C, et al. Switch to oral antibiotics in the treatment of infective

endocarditis is not associated with increased risk of mortality in non-severely ill patients. Clin Microbiol Infect. 2016. En prensa.




- Hanses F, Spaeth C, Ehrenstein BP, et al. Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection. 2010; 38(6):465-70.

- del Rio A, Cervera C, Moreno A, et al. Patients at risk of complications of Staphylococcus aureus bloodstream infection. Clin Infect Dis. 2009; 48 Suppl 4:S246-53.

- Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of

infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128.

staphylococcus aureus -...

Documents